Joan Hernandez-McClain

Chromosome 14q loss defines a molecular subtype of clear-cell renal cell carcinoma associated with poor prognosis

Federico A. Monzon, Karla Alvarez, L. E. Peterson et al. · Modern Pathology · 2011 · 133 citations · Full text

Medicine, Genetics, Molecular Genetics +11

Vaccination of Renal Cell Cancer Patients With Modified Vaccinia Ankara Delivering the Tumor Antigen 5T4 (TroVax) Alone or Administered in Combination With Interferon-α (IFN-α)

Robert J. Amato, William Shingler, Madusha Goonewardena et al. · Journal of Immunotherapy · 2009 · 78 citations

Medicine, Immunology, Oncology +17

Vaccination of Renal Cell Cancer Patients with Modified Vaccinia Ankara Delivering Tumor Antigen 5T4 (TroVax) Administered with Interleukin 2: A Phase II Trial

Robert J. Amato, William Shingler, Stuart Naylor et al. · Clinical Cancer Research · 2008 · 62 citations

Medicine, Immunology, Oncology +17

Vaccination of Prostate Cancer Patients With Modified Vaccinia Ankara Delivering the Tumor Antigen 5T4 (TroVax)

Robert J. Amato, Noel Drury, Stuart Naylor et al. · Journal of Immunotherapy · 2008 · 57 citations

Veterinary Medicine, Immunology, Oncology +17

Bone-Targeted Therapy

Robert J. Amato, Joan Hernandez-McClain, Haby Henary · American Journal of Clinical Oncology · 2008 · 31 citations

Medicine, Oncology, Pharmacology +17